feed,title,long_url,short_url
Benzinga,Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings,https://benzinga.com/general/biotech/22/09/28918943/theravance-outlines-250m-plan-to-buy-back-its-shares-from-gsk,https://bit.ly/3RYLCqs
